Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma

NCT02724904 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Drug logistics

Conditions

Lymphoma

Interventions

PROCEDURE: Allogeneic stem cell transplantation
DRUG: Fludarabine
DRUG: Thiotepa
DRUG: Methotrexate

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]